The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Zachariah Meyers was charged with more than 300 felonies, including trafficking in minors, sexual extortion, unlawful contact with a minor, distribution of child sexual abuse material, among other off...
Investigators in the Nancy Guthrie missing persons case are not looking into any new names, Pima County Sheriff Chris Nanos said, amid challenges with mixed DNA found at the 84-year-old's Arizona home...
Ambassador Ric Grenell shared surveillance footage of a suspect, whom he labeled a "terrorist," accused of carrying out a “targeted attack" that vandalized the Trump-Kennedy Center’s outdoor ice rink....
loading...